Fuan Pharmaceutical Group Co Cash Flow-to-Debt Ratio
Fuan Pharmaceutical Group Co cash flow-to-debt ratio. Fuan Pharmaceutical Group Co (300194) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of CN¥100.27 Million could theoretically repay 0% of its total liabilities (CN¥1.51 Billion) in one year. Check how high is Fuan Pharmaceutical Group Co's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Fuan Pharmaceutical Group Co (2007–2025)
Cash flow-to-debt ratio of Fuan Pharmaceutical Group Co from 2007 to 2025. Historical debt coverage capacity for Fuan Pharmaceutical Group Co across 19 annual periods. Check how aggressively does Fuan Pharmaceutical Group Co reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Fuan Pharmaceutical Group Co Cash Flow-to-Debt Ratio by Year (2007–2025)
Fuan Pharmaceutical Group Co cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Fuan Pharmaceutical Group Co. For the full cash flow conversion analysis, see how efficiently does Fuan Pharmaceutical Group Co generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥312.32 Million | CN¥1.40 Billion | ▲ +16.3% |
| 2024 | 0.19x | CN¥303.59 Million | CN¥1.58 Billion | ▲ +6.7% |
| 2023 | 0.18x | CN¥328.98 Million | CN¥1.83 Billion | ▲ +2.4% |
| 2022 | 0.18x | CN¥339.50 Million | CN¥1.93 Billion | ▲ +25.8% |
| 2021 | 0.14x | CN¥257.13 Million | CN¥1.84 Billion | ▲ +21.8% |
| 2020 | 0.11x | CN¥162.55 Million | CN¥1.42 Billion | ▼ -71.0% |
| 2019 | 0.40x | CN¥295.63 Million | CN¥746.59 Million | ▼ -11.4% |
| 2018 | 0.45x | CN¥267.68 Million | CN¥598.62 Million | ▼ -48.9% |
| 2017 | 0.87x | CN¥453.37 Million | CN¥518.24 Million | ▲ +1.5% |
| 2016 | 0.86x | CN¥374.16 Million | CN¥434.00 Million | ▲ +83.6% |
| 2015 | 0.47x | CN¥161.03 Million | CN¥342.91 Million | ▲ +287.3% |
| 2014 | -0.25x | CN¥-31.27 Million | CN¥124.69 Million | ▼ -138.8% |
| 2013 | 0.65x | CN¥89.61 Million | CN¥138.47 Million | ▼ -13.2% |
| 2012 | 0.75x | CN¥62.77 Million | CN¥84.20 Million | ▲ +43.3% |
| 2011 | 0.52x | CN¥64.85 Million | CN¥124.69 Million | ▼ -68.0% |
| 2010 | 1.62x | CN¥105.74 Million | CN¥65.09 Million | ▲ +185.6% |
| 2009 | 0.57x | CN¥62.75 Million | CN¥110.31 Million | ▲ +6.1% |
| 2008 | 0.54x | CN¥49.23 Million | CN¥91.83 Million | ▲ +105.7% |
| 2007 | 0.26x | CN¥18.92 Million | CN¥72.58 Million | — |